Skip to main content

WW INTERNATIONAL, INC.

For the period ended Jun 30, 2025. Filed Aug 11, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 11, 2025

WW$11.31-11.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cautionary Notice Regarding Forward-Looking Statements

Except for historical information contained herein, this Quarterly Report on Form 10-Q includes “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including, in particular, the statements about our plans, strategies, objectives and prospects under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We have generally used the words “may,” “will,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “aim” and similar expressions in this Quarterly Report on Form 10-Q to identify forward-looking statements. We have based these forward-looking statements on our current views with respect to future events and financial performance. Actual results could differ materially from those projected in these forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions, including, among other things:

our recent emergence from bankruptcy, which could adversely affect our business and relationships and subjects us to risks and uncertainties;

competition from other weight management and health and wellness industry participants or the development of more effective or more favorably perceived weight management methods;

our failure to continue to retain and grow our subscriber base;

our ability to be a leader in the rapidly evolving and increasingly competitive clinical weight management and weight loss market;

our ability to continue to develop new, innovative services and products and enhance our existing services and products or the failure of our services, products or brands to continue to appeal to the market, or our ability to successfully expand into new channels of distribution or respond to consumer trends or sentiment;

regulatory, reputational and other risks associated with our former compounded GLP-1 offering;

our ability to successfully implement strategic initiatives;

our ability to evolve our community offerings to meet the evolving preferences of our members;

the effectiveness and efficiency of our advertising and marketing programs, including the strength of our social media presence;

the impact on our reputation of actions taken by our franchisees, licensees, suppliers, affiliated provider entities, PCs’ healthcare professionals, and other partners, including as a result of our acquisition of Weekend Health, Inc., doing business as Sequence (“Sequence”) (the “Acquisition”);

the recognition of asset impairment charges;

the loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate our workforce;

our chief executive officer transition;

our ability to successfully make acquisitions or enter into collaborations or joint ventures, including our ability to successfully integrate, operate or realize the anticipated benefits of such businesses, including with respect to Sequence;

uncertainties related to a downturn in general economic conditions or consumer confidence, including as a result of the existing inflationary environment, changes in tariffs and escalating trade tensions, rising interest rates, the potential impact of political and social unrest and increased volatility in the credit and capital markets;

the seasonal nature of our business;

our failure to maintain effective internal control over financial reporting;

the impact of events that impede accessing resources or discourage or impede people from gathering with others;

the early termination by us of leases;

the inability to renew certain of our licenses, or the inability to do so on terms that are favorable to us;

the impact of our substantial amount of debt, debt service obligations and debt covenants, and our exposure to variable rate indebtedness;

the ability to generate sufficient cash to service our debt and satisfy our other liquidity requirements;

uncertainties regarding the satisfactory operation of our technology or systems;

the impact of data security breaches and other malicious acts or privacy concerns, including the costs of compliance with evolving privacy laws and regulations;

our ability to successfully integrate and use artificial intelligence in our business;

our ability to enforce our intellectual property rights both domestically and internationally, as well as the impact of our involvement in any claims related to intellectual property rights;

the impact of existing and future laws and regulations, including federal and state regulations relating to compounded medications;

risks related to our exposure to extensive and complex healthcare laws and regulations as a result of the Acquisition;

the outcomes of litigation or regulatory actions;

risks and uncertainties associated with our international operations, including regulatory, economic, political, social, intellectual property, and foreign currency risks, which risks may be exacerbated as a result of war and terrorism;

risks related to the Acquisition, including risks that the Acquisition may not achieve its intended results;

the possibility that we could fail to maintain the listing of our common stock on Nasdaq;

risks related to the actions of activist shareholders and anti-takeover provisions in our articles of incorporation and bylaws;

uncertainty and continuing risks associated with our ability to achieve our goals; and

other risks and uncertainties, including those included in this Quarterly Report on Form 10-Q and those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission (the “SEC”).

You should not put undue reliance on any forward-looking statements. You should understand that many important factors, including those discussed herein, could cause our results to differ materially from those expressed or suggested in any forward-looking statement. Except as required by law, we do not undertake any obligation to update or revise these forward-looking statements to reflect new information or events or circumstances that occur after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events or otherwise.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.